Neuroscience
Bipolar Disorder
94%
Glutamic Acid
91%
Meta-Analysis
88%
Nuclear Magnetic Resonance Spectroscopy
67%
Major Depressive Disorder
66%
Placebo
57%
Antidepressant
53%
Glutamine
50%
Natural Language Processing
34%
Paliperidone
34%
Spectroscopy
27%
Mental Instability
26%
Antipsychotic
26%
Bipolar Depression
25%
Depressive Disorder
24%
Frontal Lobe
22%
Citalopram
22%
Ketamine
22%
Anterior Cingulate Cortex
21%
Selective Serotonin Reuptake Inhibitor
19%
Mental Disorder
17%
Relapse Prevention
17%
Inositol
13%
Juvenile Myoclonic Epilepsy
11%
N-Acetylaspartic Acid
11%
Reboxetine
11%
Lurasidone
11%
Affective Psychosis
11%
Mixed Anxiety and Depression
11%
Glutaminase
11%
Serotonin Transporter
11%
Hepatitis C
11%
Functional Magnetic Resonance Imaging
11%
Interferon
11%
Fenfluramine
11%
Randomized Controlled Trial
11%
ICD-10
9%
Escitalopram
8%
In Vivo
7%
Mood Disorder
7%
5-HTTLPR
6%
Brain Network
6%
Substance Misuse Disorders
6%
Clinical Assessment
5%
Decanoic Acid
5%
Palmitic Acid
5%
Occipital Lobe
5%
Medicine and Dentistry
Bipolar Disorder
94%
Meta-Analysis
47%
Mental Health Service
38%
Mental Instability
38%
Early Intervention
37%
Language Processing
35%
Placebo
35%
Antidepressant
34%
Mental Health
32%
Mental Disorder
31%
Systematic Review
31%
Electronic Health Record
29%
Cohort Analysis
28%
Paliperidone
22%
Major Depressive Episode
21%
Relapse Prevention
17%
Antipsychotic
15%
Clinician
15%
Depressive Disorder
13%
Network Meta-Analysis
13%
Aripiprazole
13%
Mixed Anxiety and Depression
13%
Therapy Delay
13%
Diagnostic Delay
13%
Diseases
12%
Randomized Controlled Trial
11%
Proton Nuclear Magnetic Resonance
11%
Lurasidone
11%
Combination Therapy
11%
Ketamine
11%
Glyceryl Trinitrate
11%
Bipolar Depression
11%
Glutamic Acid
11%
Affective Psychosis
11%
Therapeutic Use
11%
Antidepressant Medication
11%
Diagnosis of Schizophrenia
11%
Biomedical Research
9%
ICD-10
9%
Depressive Psychosis
9%
Hazard Ratio
8%
Proportional Hazards Model
8%
Mood Disorder
6%
Personality Disorder
6%
Substance Misuse Disorders
6%
Antidepressant Therapy
6%
Sildenafil
6%
Effect Size
6%
Side Effect
5%
Maintenance Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bipolar Disorder
100%
Antidepressant
59%
Placebo
53%
Cohort Study
34%
Major Depression
33%
Selective Serotonin Reuptake Inhibitor
29%
Mental Instability
22%
Glutamic Acid
22%
Tamoxifen
22%
Ketamine
22%
Paliperidone
22%
Randomized Controlled Trial
18%
Depressive Disorder
16%
Glutamine
16%
Sodium Valproate
14%
Normal Human
14%
Aripiprazole
13%
Mixed Anxiety and Depression
13%
Antipsychotic
12%
Combination Therapy
11%
Serotonin Transporter
11%
Therapeutic Use
11%
Dose-Response Relationship
11%
Glyceryl Trinitrate
11%
Fenfluramine
11%
Base
9%
Diseases
9%
Mania
7%
Side Effect
7%
Remission
6%
Venlafaxine
6%
Negative Syndrome
6%
Tolerability
5%
Olanzapine
5%
Positive Syndrome
5%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
5%
Pharmacotherapy
5%
Monotherapy
5%
